VION Biosciences Completes Acquisition of CTL, Bolstering Its Functional Immune Monitoring Capabilities VION Biosciences (“VION”), a life sciences company focused on building differentiated capabilities across research, diagnostics, and drug development workflows, has announced the successful completion of its acquisition of…
Merck Launches Tender Offer to Acquire Terns Pharmaceuticals, Inc. Merck & Co., Inc., known as MSD outside the United States and Canada, has officially launched a cash tender offer through one of its subsidiaries to acquire all outstanding shares of…
enGene Confirms Corporate Name Change to enGene Therapeutics Inc enGene Therapeutics Inc., a clinical-stage biotechnology company focused on the development of non-viral genetic medicines, has announced that it will officially adopt its new corporate name, “enGene Therapeutics Inc.,” effective April…
Gilead to Acquire Tubulis to Enhance Oncology Portfolio with Potentially Best-in-Class ADC and Advanced Platform Gilead Sciences has announced that it has entered into a definitive agreement to acquire Tubulis GmbH, a Germany-based clinical-stage biotech specializing in next-generation antibody-drug conjugates…
TriSalus Life Sciences Names Richard Marshall, MD, Chief Medical Officer TriSalus Life Sciences, a clinical-stage oncology company focused on integrating innovative drug delivery technologies with standard-of-care therapies and immunotherapeutic approaches, has announced the appointment of Richard Marshall, MD, as its…
ZIVO Bioscience Enters Large-Scale Manufacturing Partnership with Cyanotech Corporation to Produce Zivolife™ Algal Biomass Zivo Bioscience, Inc. (OTCQB: ZIVO), a research-driven biotech and agtech innovator specializing in therapeutic, medicinal, and nutritional products derived from proprietary algal cultures, has announced a…
Bridge Dental Group Strengthens Its Growing Network by Adding Foothill Family Dental Group and Peak Dental Specialists Bridge Dental Group has announced a significant expansion of its footprint in the United States through a new partnership with two well-established dental…
Clarametyx Biosciences Enhances Leadership Team to Advance Clinical Development Initiatives Clarametyx Biosciences, Inc., a clinical-stage biotechnology company focused on developing immune-enabling therapies and vaccines to combat biofilm-driven chronic respiratory diseases, has announced key leadership promotions within its executive team. These…
Tenpoint Therapeutics and PHIL Collaborate to Introduce YUVEZZI™ Direct-to-Patient Cash Program, Improving Access and Affordability for Presbyopia Care Tenpoint Therapeutics, a company focused on advancing innovative treatments in eye care, has partnered with PHIL Inc. to introduce a new Direct-to-Patient…
SV Health Investors Completes Acquisition of EpiVax SV Health Investors has announced the acquisition of EpiVax, Inc., a well-established contract research organization (CRO) specializing in immunogenicity risk assessment for pharmaceutical and biotechnology companies. The transaction marks a new platform investment…
FDA Clears Lilly’s Foundayo™ (orforglipron), the First GLP-1 Weight Loss Pill with No Food or Timing Restrictions Eli Lilly and Company has announced a major milestone in the treatment of obesity with the approval of Foundayo (orforglipron) by the U.S.…
RefleXion Achieves Broader Medicare Reimbursement Approval for SCINTIX Cancer Therapy RefleXion Medical has announced a significant advancement in reimbursement support for its innovative SCINTIX® autonomous radiotherapy platform, as Noridian Healthcare Solutions, LLC has established payment rates for the therapy in…